NASDAQ:SLN Silence Therapeutics (SLN) News Today $9.82 +0.06 (+0.61%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$9.67▼$10.1450-Day Range$4.90▼$10.7452-Week Range$4.55▼$17.99Volume4,228 shsAverage Volume30,357 shsMarket Capitalization$293.89 millionP/E RatioN/ADividend YieldN/APrice Target$44.75 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineThe Silence of the Lambs: Where to Watch & Stream Onlineyahoo.com - September 18 at 3:03 PMMeghan Markle's silence will benefit Kate Middleton by giving her 'unique platform' backmirror.co.uk - July 30 at 8:45 AMJamie Foxx shares reason behind silence as he says he 'knows a lot of people were waiting'mirror.co.uk - July 30 at 8:45 AMSilence Therapeutics: No Reason For It To Fall So Muchmsn.com - July 14 at 11:06 PMSilence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaborationfinance.yahoo.com - July 11 at 7:15 AMMorgan Stanley Keeps Their Buy Rating on Silence Therapeutics (SLN)markets.businessinsider.com - June 12 at 9:53 PMM28 Capital Management LP Invests $2.23 Million in Silence Therapeutics plc (NASDAQ:SLN)marketbeat.com - May 26 at 2:50 PMSilence Therapeutics plc (NASDAQ:SLN) Expected to Earn Q2 2023 Earnings of ($0.65) Per Sharemarketbeat.com - May 22 at 1:27 AMmarketbeat.com - May 18 at 2:34 PMmarketbeat.com - May 18 at 2:04 PMAnalysts Offer Insights on Services Companies: Silence Therapeutics (SLN), Paypal Holdings (PYPL) and Liberty Global C (LBTYK)markets.businessinsider.com - May 11 at 7:19 AMSilence Therapeutics overweight at Morgan Stanley on RNAi platformmsn.com - May 8 at 1:57 PMAnalysts Conflicted on These Services Names: Silence Therapeutics (SLN) and Planet Fitness (PLNT)markets.businessinsider.com - May 8 at 8:56 AMmarketbeat.com - April 27 at 2:59 PMAmerican Depositary Receipts of European Equities Rise As Banking Sector Worries Easemsn.com - March 29 at 12:57 PMSilence Therapeutics to Present at Guggenheim’s Genomic Medicines and Rare Disease Daysfinance.yahoo.com - March 29 at 7:57 AMSilence Therapeutics plc (NASDAQ:SLN) Q4 2022 Earnings Call Transcriptinsidermonkey.com - March 20 at 9:53 PMSilence Therapeutics' (SLN) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - March 17 at 12:12 PMTweet from Aaron Rodgers’ account prompts confusion after breaking silencenypost.com - March 16 at 9:43 AMmarketbeat.com - March 15 at 9:36 AMSilence Therapeutics plc: Silence Therapeutics Reports Fourth Quarter and Full Year 2022 Resultsfinanznachrichten.de - March 15 at 8:44 AMSilence Therapeutics Reports Fourth Quarter and Full Year 2022 Resultsbusinesswire.com - March 15 at 7:15 AMSLN Silence Therapeutics plcseekingalpha.com - March 13 at 11:06 PMSilence Therapeutics (SLN) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - March 8 at 2:31 AMCovert cameras and alleged hacking: how bust payments company Wirecard ‘hired spies and lawyers to silence critics’theguardian.com - March 6 at 4:34 AMSilence Therapeutics PLC Sponsored ADR (SLN) Stock Jumps 9.3%: Will It Continue to Soar?finance.yahoo.com - March 6 at 4:34 AMSilence Therapeutics plc (NASDAQ:SLN) Short Interest Down 22.2% in Februarymarketbeat.com - March 3 at 3:24 PMSilence Therapeutics to Report Fourth Quarter and Full Year 2022 Results on March 15, 2023businesswire.com - March 2 at 8:44 AMZacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings and Acer Therapeuticsfinance.yahoo.com - January 19 at 9:43 AMSilence Therapeutics PLC Sponsored ADR (SLN) Upgraded to Strong Buy: What Does It Mean for the Stock?finance.yahoo.com - January 4 at 2:35 PMSilence Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 8:34 AMSilence Therapeutics plc (NASDAQ:SLN) Short Interest Updatemarketbeat.com - December 30 at 11:31 AMSilence Therapeutics (NASDAQ:SLN) Now Covered by Morgan Stanleymarketbeat.com - December 9 at 7:47 AMSilence Therapeutics plc Expected to Earn FY2022 Earnings of ($0.44) Per Share (NASDAQ:SLN)marketbeat.com - December 8 at 7:27 AMSilence Therapeutics (NASDAQ:SLN) Shares Gap Down After Analyst Downgrademarketbeat.com - December 6 at 11:18 AMWhat’s Changed Since TIME Named the ‘Silence Breakers’ Person of the Yearmsn.com - December 6 at 7:46 AMHC Wainwright Cuts Silence Therapeutics (NASDAQ:SLN) Price Target to $80.00marketbeat.com - December 6 at 7:32 AMSilence Therapeutics (NASDAQ:SLN) PT Lowered to $29.00marketbeat.com - November 21 at 3:56 AMSilence Therapeutics plc (NASDAQ:SLN) Sees Large Decline in Short Interestmarketbeat.com - November 12 at 8:56 PM‘The Opposite of Fear Is Love’: Christos Passalis on Grief and Healing in Thessaloniki Competition Title ‘Silence 6-9’msn.com - November 7 at 5:03 AMSilence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a) at the American Heart Association (AHA) 2022 Annual Meetingfinance.yahoo.com - November 5 at 5:57 PMSilence Therapeutics' Thalassemia Hopeful Shows Favorable Safety Profile In Early Stage Studyfinance.yahoo.com - October 7 at 2:10 AMSilence Therapeutics plc (NASDAQ:SLN) Short Interest Up 50.3% in Septembermarketbeat.com - September 28 at 3:32 PMColumn: Amid the pageantry and corgis, what made the queen’s funeral extraordinary was silencelatimes.com - September 22 at 11:57 AMSilence Therapeutics wins FDA’s fast track status for blood cancer therapyseekingalpha.com - September 9 at 9:17 PMShort Interest in Silence Therapeutics plc (NASDAQ:SLN) Grows By 24.7%marketbeat.com - August 28 at 5:23 PMFY2022 EPS Estimates for Silence Therapeutics plc Increased by William Blair (NASDAQ:SLN)marketbeat.com - August 19 at 6:33 AMSilence Therapeutics Announces Pricing of Underwritten Offeringfinance.yahoo.com - August 11 at 9:04 PMSilence Therapeutics (SLN) Investor Presentation - Slideshowseekingalpha.com - July 25 at 8:22 PMmarketbeat.com - June 22 at 10:29 AM Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address SLN Media Mentions By Week SLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼1.040.68▲Average Medical News Sentiment SLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼10▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MCRB News NBTX News PMVP News NUVB News MGNX News TERN News NATR News INZY News ERAS News FULC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:SLN) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.